Abstract
Tiapride, a substituted benzamide derivative closely related to metoclopramide, reduced levodopa-induced peak dose involuntary movements in 16 patients with idiopathic Parkinson's disease. However, an unacceptable increase in disability from Parkinsonism with aggravation of end-of-dose akinesia led to its cessation in 14 patients. Tiapride had no effect on levodopa-induced early morning of "off-period" segmental dystonia. These results fail to support the notion that levodopa-induced dyskinesias are caused by overstimulation of a separate group of dopamine receptors.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barbeau A. Letter: Diphasic dyskinesia during levodopa therapy. Lancet. 1975 Mar 29;1(7909):756–756. doi: 10.1016/s0140-6736(75)91676-1. [DOI] [PubMed] [Google Scholar]
- Bédard P., Parkes J. D., Marsden C. D. Effect of new dopamine-blocking agent (oxiperomide) on drug-induced dyskinesias in Parkinson's disease and spontaneous dyskinesias. Br Med J. 1978 Apr 15;1(6118):954–956. doi: 10.1136/bmj.1.6118.954. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cools A. R., Van Rossum J. M. Excitation-mediating and inhibition-mediating dopamine-receptors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacologia. 1976 Feb 2;45(3):243–254. doi: 10.1007/BF00421135. [DOI] [PubMed] [Google Scholar]
- Costall B., Naylor R. J. Neuroleptic antagonism of dyskinetic phenomena. Eur J Pharmacol. 1975 Sep-Oct;33(2):301–312. doi: 10.1016/0014-2999(75)90174-0. [DOI] [PubMed] [Google Scholar]
- Jenner P., Elliott P. N., Clow A., Reavill C., Marsden C. D. A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs. J Pharm Pharmacol. 1978 Jan;30(1):46–48. doi: 10.1111/j.2042-7158.1978.tb13151.x. [DOI] [PubMed] [Google Scholar]
- Klawans H. L., Jr, Weiner W. J. Attempted use of haloperidol in the treatment of L-dopa induced dyskinesias. J Neurol Neurosurg Psychiatry. 1974 Apr;37(4):427–430. doi: 10.1136/jnnp.37.4.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lavy S., Melamed E., Penchas S. Tardive dyskinesia associated with metoclopramide. Br Med J. 1978 Jan 14;1(6105):77–78. doi: 10.1136/bmj.1.6105.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lees A. J., Shaw K. M., Stern G. M. "Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease. Lancet. 1977 Nov 12;2(8046):1034–1034. doi: 10.1016/s0140-6736(77)92939-7. [DOI] [PubMed] [Google Scholar]
- Lees A. J., Shaw K. M., Stern G. M. Baclofen in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1978 Aug;41(8):707–708. doi: 10.1136/jnnp.41.8.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLennan H., York D. H. The action of dopamine on neurones of the caudate nucleus. J Physiol. 1967 Apr;189(3):393–402. doi: 10.1113/jphysiol.1967.sp008175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Olson L., Seiger A., Fuxe K. Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. Brain Res. 1972 Sep 15;44(1):283–288. doi: 10.1016/0006-8993(72)90385-x. [DOI] [PubMed] [Google Scholar]
- Robinson O. P. Metoclopramide--side effects and safety. Postgrad Med J. 1973 Jul;49 (Suppl 4):suppl 4–4:80. [PubMed] [Google Scholar]
- Tarsy D., Parkes J. D., Marsden C. D. Metoclopramide and pimozide in Parkinson's disease and levodopa-induced dyskinesias. J Neurol Neurosurg Psychiatry. 1975 Apr;38(4):331–335. doi: 10.1136/jnnp.38.4.331. [DOI] [PMC free article] [PubMed] [Google Scholar]